683 Capital Management’s Chemours CC Stock Holding History

683 Capital Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-282,300	Closed	-$1.51M	–	69
2015 Q4	$1.51M	Hold	282,300	–	–	0.21%	70
2015 Q3	$1.83M	Buy	+282,300	New	+$2.95M	0.27%	61

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

683 Capital Management's CC Position: Q3 2017 in Review

683 Capital Management sold out of Chemours (CC) in Q3 2017, closing a stake of 200,000 shares — an estimated $7.58M sold.

683 Capital Management first reported a position in CC in Q3 2015 and held it in 7 quarters. The position peaked at $18.1M in Q1 2017. 499 funds tracked by Wall St. Rank hold CC as of Q3 2017.

683 Capital Management reported no remaining Chemours position as of Q3 2017 after selling out during the quarter.
683 Capital Management sold 200,000 Chemours shares in Q3 2017, an estimated $7.58M.
683 Capital Management first reported a position in Chemours in Q3 2015 and held it in 7 quarters.
683 Capital Management's Chemours position peaked at $18.1M in Q1 2017.
499 funds tracked by Wall St. Rank held Chemours as of Q3 2017.

Based on 683 Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.